AKAnisha Keshavan

Anisha Keshavan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anisha Keshavan has a total of 484 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Standardizing Survey Data Collection to Enhance Reproducibility: Development and Comparative Evaluation of the ReproSchema Ecosystem

    by Yibei Chen, Dorota Jarecka, Sanu Ann Abraham, Remi Gau, Evan Ng, Daniel M Low, Isaac Bevers, Alistair Johnson, Anisha Keshavan, Arno Klein, et al.

    Background: Inconsistencies in survey-based (eg, questionnaire) data collection across biomedical, clinical, behavioral, and social sciences pose challenges to research reproducibility. ReproSchema is an ecosystem that standardizes survey design and facilitates reproducible data collection through a schema-centric framework, a library of reusable assessments, and computational tools for validation and conversion. Unlike conventional survey platforms that primarily offer graphical user interface–based survey creation, ReproSchema provides a structured, modular approach for defining and managing survey components, enabling interoperability and adaptability across diverse research settings. Objective: This study examines ReproSchema’s role in enhancing research reproducibility and reliability. We introduce its conceptual and practical foundations, compare it against 12 platforms to assess its effectiveness in addressing inconsistencies in data collection, and demonstrate its application through 3 use cases: standardizing required mental health survey common data elements, tracking changes in longitudinal data collection, and creating interactive checklists for neuroimaging research. Methods: We describe ReproSchema’s core components, including its schema-based design; reusable assessment library with >90 assessments; and tools to validate data, convert survey formats (eg, REDCap [Research Electronic Data Capture] and Fast Healthcare Interoperability Resources), and build protocols. We compared 12 platforms—Center for Expanded Data Annotation and Retrieval, formr, KoboToolbox, Longitudinal Online Research and Imaging System, MindLogger, OpenClinica, Pavlovia, PsyToolkit, Qualtrics, REDCap, SurveyCTO, and SurveyMonkey—against 14 findability, accessibility, interoperability, and reusability (FAIR) principles and assessed their support of 8 survey functionalities (eg, multilingual support and automated scoring). Finally, we applied ReproSchema to 3 use cases—NIMH-Minimal, the Adolescent Brain Cognitive Development and HEALthy Brain and Child Development Studies, and the Committee on Best Practices in Data Analysis and Sharing Checklist—to illustrate ReproSchema’s versatility. Results: ReproSchema provides a structured framework for standardizing survey-based data collection while ensuring compatibility with existing survey tools. Our comparison results showed that ReproSchema met 14 of 14 FAIR criteria and supported 6 of 8 key survey functionalities: provision of standardized assessments, multilingual support, multimedia integration, data validation, advanced branching logic, and automated scoring. Three use cases illustrating ReproSchema’s flexibility include standardizing essential mental health assessments (NIMH-Minimal), systematically tracking changes in longitudinal studies (Adolescent Brain Cognitive Development and HEALthy Brain and Child Development), and converting a 71-page neuroimaging best practices guide into an interactive checklist (Committee on Best Practices in Data Analysis and Sharing). Conclusions: ReproSchema enhances reproducibility by structuring survey-based data collection through a structured, schema-driven approach. It integrates version control, manages metadata, and ensures interoperability, maintaining consistency across studies and compatibility with common survey tools. Planned developments, including ontology mappings and semantic search, will broaden its use, supporting transparent, scalable, and reproducible research across disciplines.


  • Open Access

    Standardizing Survey Data Collection to Enhance Reproducibility: Development and Comparative Evaluation of the ReproSchema Ecosystem (Preprint)

    by Yibei Chen, Dorota Jarecka, Sanu Ann Abraham, Remi Gau, Evan Ng, Daniel M Low, Isaac Bevers, Alistair Johnson, Anisha Keshavan, Arno Klein, et al.

    BACKGROUND Inconsistencies in survey-based (eg, questionnaire) data collection across biomedical, clinical, behavioral, and social sciences pose challenges to research reproducibility. ReproSchema is an ecosystem that standardizes survey design and facilitates reproducible data collection through a schema-centric framework, a library of reusable assessments, and computational tools for validation and conversion. Unlike conventional survey platforms that primarily offer graphical user interface–based survey creation, ReproSchema provides a structured, modular approach for defining and managing survey components, enabling interoperability and adaptability across diverse research settings. OBJECTIVE This study examines ReproSchema’s role in enhancing research reproducibility and reliability. We introduce its conceptual and practical foundations, compare it against 12 platforms to assess its effectiveness in addressing inconsistencies in data collection, and demonstrate its application through 3 use cases: standardizing required mental health survey common data elements, tracking changes in longitudinal data collection, and creating interactive checklists for neuroimaging research. METHODS We describe ReproSchema’s core components, including its schema-based design; reusable assessment library with >90 assessments; and tools to validate data, convert survey formats (eg, REDCap [Research Electronic Data Capture] and Fast Healthcare Interoperability Resources), and build protocols. We compared 12 platforms—Center for Expanded Data Annotation and Retrieval, formr, KoboToolbox, Longitudinal Online Research and Imaging System, MindLogger, OpenClinica, Pavlovia, PsyToolkit, Qualtrics, REDCap, SurveyCTO, and SurveyMonkey—against 14 findability, accessibility, interoperability, and reusability (FAIR) principles and assessed their support of 8 survey functionalities (eg, multilingual support and automated scoring). Finally, we applied ReproSchema to 3 use cases—NIMH-Minimal, the Adolescent Brain Cognitive Development and HEALthy Brain and Child Development Studies, and the Committee on Best Practices in Data Analysis and Sharing Checklist—to illustrate ReproSchema’s versatility. RESULTS ReproSchema provides a structured framework for standardizing survey-based data collection while ensuring compatibility with existing survey tools. Our comparison results showed that ReproSchema met 14 of 14 FAIR criteria and supported 6 of 8 key survey functionalities: provision of standardized assessments, multilingual support, multimedia integration, data validation, advanced branching logic, and automated scoring. Three use cases illustrating ReproSchema’s flexibility include standardizing essential mental health assessments (NIMH-Minimal), systematically tracking changes in longitudinal studies (Adolescent Brain Cognitive Development and HEALthy Brain and Child Development), and converting a 71-page neuroimaging best practices guide into an interactive checklist (Committee on Best Practices in Data Analysis and Sharing). CONCLUSIONS ReproSchema enhances reproducibility by structuring survey-based data collection through a structured, schema-driven approach. It integrates version control, manages metadata, and ensures interoperability, maintaining consistency across studies and compatibility with common survey tools. Planned developments, including ontology mappings and semantic search, will broaden its use, supporting transparent, scalable, and reproducible research across disciplines.

  • Open Access

    Brain Charts for People Living with Multiple Sclerosis

    by Anisha Keshavan, Daniel Peterson, Aaron Alexander-Bloch, Kelly Leyden

    Multiple sclerosis (MS) is associated with brain volume loss throughout the disease course. Currently available automated segmentation methods can measure total brain volume as well as ventricular volume, which has been advocated as a robust surrogate for brain volume based on clinically acquired magnetic resonance imaging (MRI). However, brain and ventricle volumes change naturally with age and may be susceptible to biases from differences in acquisition hardware, imaging protocol, and image quality, in addition to statistical biases such as regression to the mean. In this work, brain charts for people living with MS were established that account for patient biological sex, age, and differences in acquisition and image quality. 379 subjects were imaged longitudinally at 5 MS centers using 13 MRI scanner models from 2 scanner manufacturers employing a variety of protocols that included T1-weighted and T2-weighted FLAIR imaging. Generalized Additive Models for Location Scale and Shape (GAMLSS) were employed, and scanner metadata as well as automated assessments of image quality were modeled. Cross-sectional brain charts and conditional, longitudinal brain charts were estimated separately in female and male participants resulting in interpretable and intuitive centile estimates. These findings indicate that brain charts for people living with MS are a promising method for turning quantitative volumetrics into actionable knowledge about a patient’s disease. Highlights: Interpreting observed changes in brain volume can be challenging due to statistical biases including regression to the mean. Brain size changes naturally with age and may be susceptible to biases associated with acquisition hardware, imaging protocol, and image quality. Brain charts for people living with MS are a promising method for translating quantitative volumetrics into interpretable knowledge about a patient’s disease.


  • Open Access

    Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

    by Tanuja Chitnis, John Foley, Carolina Ionete, Nabil K. El Ayoubi, Shrishti Saxena, Patricia Gaitan-Walsh, Hrishikesh Lokhande, Anu Paul, Fermisk Saleh, Howard Weiner, et al.


  • Open Access

    Clinical Validation of a Multi-protein, Serum-based Assay for Disease Activity Assessments in Multiple Sclerosis

    by Tanuja Chitnis, John Foley, Carolina Ionete, Nabil K. El Ayoubi, Shrishti Saxena, Patricia Gaitan-Walsh, Hrishikesh Lokhande, Anu Paul, Fermisk Saleh, Howard Weiner, et al.

    Background and objectives: An unmet need exists for validated quantitative tools to measure multiple sclerosis (MS) disease activity and progression. We developed a custom immunoassay-based MS disease activity (MSDA) Test incorporating 18 protein concentrations into an algorithm to calculate four Disease Pathway scores (Immunomodulation, Neuroinflammation, Myelin Biology, and Neuroaxonal Integrity) and an overall Disease Activity score. The objective was to clinically validate the MSDA Test based on associations between scores and clinical/radiographic assessments. Methods: Serum samples (N=614) from patients with MS at multiple sites were split into Train (n=426; algorithm development) and Test (n=188; evaluation) subsets. Subsets were stratified by demographics, sample counts per site, and gadolinium-positive (Gd+) lesion counts; age and sex were used to demographically adjust protein concentrations. MSDA Test results were evaluated for potential association with Gd+ lesion presence/absence, new and enlarging (N/E) T2 lesion presence, and active versus stable disease status (composite endpoint combining radiographic and clinical evidence of disease activity). Results: A multi-protein model was developed (trained and cross-validated) using the Train subset. When applied to the Test subset, the model classified the Gd+ lesion presence/absence, N/E T2 lesion presence, and active versus stable disease status assessments with an area under the receiver operating characteristic (AUROC) of 0.781, 0.750, and 0.768, respectively. In each case, the multi-protein model had significantly (bootstrapped, one-sided p <0.05) greater AUROC performance when compared with the top-performing, demographically adjusted (by age and sex) single-protein model based on neurofilament light polypeptide chain. Algorithmic score thresholds corresponded to low, moderate, or high levels of disease activity. Based on the Test subset, the diagnostic odds ratios determined that the odds of having ≥1 Gd+ lesions among samples with a moderate/high Disease Activity score were 4.49 times that of a low Disease Activity score. The odds of having ≥2 Gd+ lesions among samples with a high Disease Activity score were 20.99 times that of a low/moderate Disease Activity score. Discussion: The MSDA Test was clinically validated; the multi-protein model had greater performance compared with the top-performing single-protein model. The MSDA Test may serve as a quantitative and objective tool to enhance care for MS.


  • Open Access

    Remote Digital Psychiatry for Mobile Mental Health Assessment and Therapy: MindLogger Platform Development Study

    by Arno Klein, Jon Clucas, Anirudh Krishnakumar, Satrajit S Ghosh, Wilhelm Van Auken, Benjamin Thonet, Ihor Sabram, Nino Acuna, Anisha Keshavan, Henry Rossiter, et al.

    Background: Universal access to assessment and treatment of mental health and learning disorders remains a significant and unmet need. There are many people without access to care because of economic, geographic, and cultural barriers, as well as the limited availability of clinical experts who could help advance our understanding and treatment of mental health. Objective: This study aims to create an open, configurable software platform to build clinical measures, mobile assessments, tasks, and interventions without programming expertise. Specifically, our primary requirements include an administrator interface for creating and scheduling recurring and customized questionnaires where end users receive and respond to scheduled notifications via an iOS or Android app on a mobile device. Such a platform would help relieve overwhelmed health systems and empower remote and disadvantaged subgroups in need of accurate and effective information, assessment, and care. This platform has the potential to advance scientific research by supporting the collection of data with instruments tailored to specific scientific questions from large, distributed, and diverse populations. Methods: We searched for products that satisfy these requirements. We designed and developed a new software platform called MindLogger, which exceeds the requirements. To demonstrate the platform’s configurability, we built multiple applets (collections of activities) within the MindLogger mobile app and deployed several of them, including a comprehensive set of assessments underway in a large-scale, longitudinal mental health study. Results: Of the hundreds of products we researched, we found 10 that met our primary requirements with 4 that support end-to-end encryption, 2 that enable restricted access to individual users’ data, 1 that provides open-source software, and none that satisfy all three. We compared features related to information presentation and data capture capabilities; privacy and security; and access to the product, code, and data. We successfully built MindLogger mobile and web applications, as well as web browser–based tools for building and editing new applets and for administering them to end users. MindLogger has end-to-end encryption, enables restricted access, is open source, and supports a variety of data collection features. One applet is currently collecting data from children and adolescents in our mental health study, and other applets are in different stages of testing and deployment for use in clinical and research settings. Conclusions: We demonstrated the flexibility and applicability of the MindLogger platform through its deployment in a large-scale, longitudinal, mobile mental health study and by building a variety of other mental health–related applets. With this release, we encourage a broad range of users to apply the MindLogger platform to create and test applets to advance health care and scientific research. We hope that increasing the availability of applets designed to assess and administer interventions will facilitate access to health care in the general population.


  • Open Access

    Brainhack: developing a culture of open, inclusive, community-driven neuroscience

    by Remi Gau, Stephanie Noble, Katja Heuer, Katherine L Bottenhorn, Isil Poyraz Bilgin, Yu-Fang Yang, Julia M Huntenburg, Johanna Margarete Marianne Bayer, Richard A.I. Bethlehem, Shawn A Rhoads, et al.

    Brainhack is an innovative meeting format that promotes scientific collaboration and education in an open and inclusive environment. Departing from the formats of typical scientific workshops, these events are based on grassroots projects and training, and foster open and reproducible scientific practices. We describe here the multifaceted, lasting benefits of Brainhacks for individual participants, particularly early career researchers. We further highlight the unique contributions that Brainhacks can make to the research community, contributing to scientific progress by complementing opportunities available in conventional formats.

  • Open Access

    Remote Digital Psychiatry: MindLogger for Mobile Mental Health Assessment and Therapy

    by Arno Klein, Jon Clucas, Anirudh Krishnakumar, Satrajit S. Ghosh, Wil Van Auken, Benjamin Thonet, Ihor Sabram, Nino Acuna, Anisha Keshavan, Henry Rossiter, et al.

    Background Universal access to assessment and treatment of mental health and learning disorders remains a significant and unmet need. There is a vast number of people without access to care because of economic, geographic, and cultural barriers as well as limited availability of clinical experts who could help advance our understanding of mental health. Objective To create an open, configurable software platform to build clinical measures, mobile assessments, tasks, and interventions without programming expertise. Specifically, our primary requirements include: an administrator interface for creating and scheduling recurring and customized questionnaires where end users receive and respond to scheduled notifications via an iOS or Android app on a mobile device. Such a platform would help relieve overwhelmed health systems, and empower remote and disadvantaged subgroups in need of accurate and effective information, assessment, and care. This platform has potential to advance scientific research by supporting the collection of data with instruments tailored to specific scientific questions from large, distributed, and diverse populations. Methods We conducted a search for tools that satisfy the above requirements. We designed and developed a new software platform called “MindLogger” that exceeds the above requirements. To demonstrate the tool’s configurability, we built multiple “applets” (collections of activities) within the MindLogger mobile application and deployed several, including a comprehensive set of assessments underway in a large-scale, longitudinal, mental health study. Results Of the hundreds of products we researched, we found 10 that met our primary requirements above with 4 that support end-to-end encryption, 2 that enable restricted access to individual users’ data, 1 that provides open source software, and none that satisfy all three. We compared features related to information presentation and data capture capabilities, privacy and security, and access to the product, code, and data. We successfully built MindLogger mobile and web applications, as well as web browser-based tools for building and editing new applets and for administering them to end users. MindLogger has end-to-end encryption, enables restricted access, is open source, and supports a variety of data collection features. One applet is currently collecting data from children and adolescents in our mental health study, and other applets are in different stages of testing and deployment for use in clinical and research settings. Conclusions We have demonstrated the flexibility and applicability of the MindLogger platform through its deployment in a large-scale, longitudinal, mobile mental health study, and by building a variety of other mental health-related applets. With this release, we encourage a broad range of users to apply the MindLogger platform to create and test applets to advance health care and scientific research. We hope that increasing availability of applets designed to assess and administer interventions will facilitate access to health care in the general population.


  • Open Access

    Remote Digital Psychiatry for Mobile Mental Health Assessment and Therapy: MindLogger Platform Development Study (Preprint)

    by Arno Klein, Jon Clucas, Anirudh Krishnakumar, Satrajit S Ghosh, Wilhelm Van Auken, Benjamin Thonet, Ihor Sabram, Nino Acuna, Anisha Keshavan, Henry Rossiter, et al.

    BACKGROUND Universal access to assessment and treatment of mental health and learning disorders remains a significant and unmet need. There are many people without access to care because of economic, geographic, and cultural barriers, as well as the limited availability of clinical experts who could help advance our understanding and treatment of mental health. OBJECTIVE This study aims to create an open, configurable software platform to build clinical measures, mobile assessments, tasks, and interventions without programming expertise. Specifically, our primary requirements include an administrator interface for creating and scheduling recurring and customized questionnaires where end users receive and respond to scheduled notifications via an iOS or Android app on a mobile device. Such a platform would help relieve overwhelmed health systems and empower remote and disadvantaged subgroups in need of accurate and effective information, assessment, and care. This platform has the potential to advance scientific research by supporting the collection of data with instruments tailored to specific scientific questions from large, distributed, and diverse populations. METHODS We searched for products that satisfy these requirements. We designed and developed a new software platform called MindLogger, which exceeds the requirements. To demonstrate the platform’s configurability, we built multiple applets (collections of activities) within the MindLogger mobile app and deployed several of them, including a comprehensive set of assessments underway in a large-scale, longitudinal mental health study. RESULTS Of the hundreds of products we researched, we found 10 that met our primary requirements with 4 that support end-to-end encryption, 2 that enable restricted access to individual users’ data, 1 that provides open-source software, and none that satisfy all three. We compared features related to information presentation and data capture capabilities; privacy and security; and access to the product, code, and data. We successfully built MindLogger mobile and web applications, as well as web browser–based tools for building and editing new applets and for administering them to end users. MindLogger has end-to-end encryption, enables restricted access, is open source, and supports a variety of data collection features. One applet is currently collecting data from children and adolescents in our mental health study, and other applets are in different stages of testing and deployment for use in clinical and research settings. CONCLUSIONS We demonstrated the flexibility and applicability of the MindLogger platform through its deployment in a large-scale, longitudinal, mobile mental health study and by building a variety of other mental health–related applets. With this release, we encourage a broad range of users to apply the MindLogger platform to create and test applets to advance health care and scientific research. We hope that increasing the availability of applets designed to assess and administer interventions will facilitate access to health care in the general population.


  • Open Access

    QSIPrep: An integrative platform for preprocessing and reconstructing diffusion MRI

    by Matthew Cieslak, Philip A. Cook, Xiaosong He, Fang-Cheng Yeh, Thijs Dhollander, Azeez Adebimpe, Geoffrey K. Aguirre, Danielle S. Bassett, Richard F. Betzel, Josiane Bourque, et al.

    Diffusion-weighted magnetic resonance imaging (dMRI) has become the primary method for non-invasively studying the organization of white matter in the human brain. While many dMRI acquisition sequences have been developed, they all sample q-space in order to characterize water diffusion. Numerous software platforms have been developed for processing dMRI data, but most work on only a subset of sampling schemes or implement only parts of the processing workflow. Reproducible research and comparisons across dMRI methods are hindered by incompatible software, diverse file formats, and inconsistent naming conventions. Here we introduce QSIPrep, an integrative software platform for the processing of diffusion images that is compatible with nearly all dMRI sampling schemes. Drawing upon a diverse set of software suites to capitalize upon their complementary strengths, QSIPrep automatically applies best practices for dMRI preprocessing, including denoising, distortion correction, head motion correction, coregistration, and spatial normalization. Throughout, QSIPrep provides both visual and quantitative measures of data quality as well as “glass-box” methods reporting. Taken together, these features facilitate easy implementation of best practices for processing of diffusion images while simultaneously ensuring reproducibility.